JP2025511221A5 - - Google Patents
Info
- Publication number
- JP2025511221A5 JP2025511221A5 JP2024558082A JP2024558082A JP2025511221A5 JP 2025511221 A5 JP2025511221 A5 JP 2025511221A5 JP 2024558082 A JP2024558082 A JP 2024558082A JP 2024558082 A JP2024558082 A JP 2024558082A JP 2025511221 A5 JP2025511221 A5 JP 2025511221A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- disorder
- pharmaceutical composition
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263326316P | 2022-04-01 | 2022-04-01 | |
| US63/326,316 | 2022-04-01 | ||
| PCT/US2023/064896 WO2023192802A1 (en) | 2022-04-01 | 2023-03-24 | Notch1 and notch4 decoys and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511221A JP2025511221A (ja) | 2025-04-15 |
| JP2025511221A5 true JP2025511221A5 (https=) | 2026-04-01 |
Family
ID=86054213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558082A Pending JP2025511221A (ja) | 2022-04-01 | 2023-03-24 | Ｎｏｔｃｈ１およびｎｏｔｃｈ４デコイとその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250223332A1 (https=) |
| EP (1) | EP4504766A1 (https=) |
| JP (1) | JP2025511221A (https=) |
| AU (1) | AU2023241819A1 (https=) |
| CA (1) | CA3254329A1 (https=) |
| WO (1) | WO2023192802A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| DE69332197T2 (de) | 1992-03-13 | 2003-04-17 | Organon Teknika B.V., Boxtel | Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmenten |
| US6277375B1 (en) | 1997-03-03 | 2001-08-21 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| WO2005111072A2 (en) | 2004-04-29 | 2005-11-24 | The Trustees Of Columbia University In The City Of New York | Notch-based fusion proteins and uses thereof |
| TW201329105A (zh) * | 2011-10-04 | 2013-07-16 | Thr Trustees Of Columbia University In The City Of New York | 人類ｎｏｔｃｈ１引誘物 |
| WO2017205651A1 (en) * | 2016-05-25 | 2017-11-30 | The Trustees Of Columbia University In The City Of New York | Human notch1 based fusion proteins as decoy inhibitors of jagged-notch signaling and dll-notch signaling |
-
2023
- 2023-03-24 CA CA3254329A patent/CA3254329A1/en active Pending
- 2023-03-24 JP JP2024558082A patent/JP2025511221A/ja active Pending
- 2023-03-24 EP EP23718589.7A patent/EP4504766A1/en active Pending
- 2023-03-24 WO PCT/US2023/064896 patent/WO2023192802A1/en not_active Ceased
- 2023-03-24 AU AU2023241819A patent/AU2023241819A1/en active Pending
- 2023-03-24 US US18/850,718 patent/US20250223332A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7405772B2 (ja) | アクチビンｉｉａ型受容体変異体および同変異体を含む医薬組成物 | |
| CN111108117B (zh) | 胰高血糖素样肽1受体激动剂及其用途 | |
| RU2677800C2 (ru) | Сайт-специфичный конъюгат инсулина | |
| JP2022523972A (ja) | 増殖分化因子１５併用療法 | |
| MX2013000804A (es) | Una composicion de combinacion farmaceutica y metodos para tratar la diabetes y los trastornos metabolicos. | |
| KR20190067219A (ko) | 통증 예방, 경감 또는 치료에서의 신경 흥분성 상해 관련 폴리펩타이드의 용도 | |
| TW202120530A (zh) | 神經障礙之治療 | |
| JP7650074B2 (ja) | 眼疾患を治療するための組成物及び方法 | |
| JP2022091967A (ja) | 脊髄損傷及び疼痛を処置するための抗ＲＧＭａ（Ｒｅｐｕｌｓｉｖｅ Ｇｕｉｄａｎｃｅ Ｍｏｌｅｃｕｌｅ Ａ）アンタゴニスト抗体 | |
| WO2014084027A1 (ja) | 細胞膜透過性の線維芽細胞増殖因子の医療用途 | |
| CA2891386A1 (en) | Compositions and methods for the treatment of ectodermal dysplasia | |
| JP2025511221A5 (https=) | ||
| EP2694547B1 (en) | Antibodies that bind tgf-alpha and epiregulin | |
| WO2022111612A1 (zh) | 包含抗tigit/pd-1双特异性抗体的制剂及其制备方法和用途 | |
| JP7824885B2 (ja) | 表皮水疱症の治療で使用するためのホーミングペプチド誘導デコリン複合体 | |
| WO2023240031A1 (en) | Compositions and methods for treating postural tachycardia syndrome | |
| CN100484957C (zh) | 胸腺素β4衍生物及其应用 | |
| JP2005508875A5 (https=) | ||
| EP4225372A1 (en) | Methods of treating dermatomyositis | |
| WO2025234425A1 (ja) | 新規ペプチド誘導体およびその用途 | |
| US20240092939A1 (en) | Methods and compositions comprising novel bispecific antibodies | |
| TW202604934A (zh) | 新穎胜肽衍生物及其用途 | |
| KR20260006552A (ko) | Igf-1 키메라 단백질을 이용한 치료 방법 | |
| TW202612733A (zh) | 抗ＩＬ－１１Ｒα抗體在治療甲狀腺眼病中之給藥 | |
| WO2023083243A1 (zh) | 一种抗il-17/vegf双功能融合蛋白及其用途 |